|Bid||2,993.00 x 0|
|Ask||3,003.00 x 0|
|Day's Range||2,955.00 - 3,025.00|
|52 Week Range||1,700.00 - 3,542.00|
|Beta (5Y Monthly)||0.65|
|PE Ratio (TTM)||75.74|
|Forward Dividend & Yield||61.79 (2.09%)|
|Ex-Dividend Date||Nov 05, 2020|
|1y Target Est||N/A|
European regulators greenlight J&J COVID-19 vaccine, but also warn blood clots will be listed as potential side effect.
Brazil is in talks to buy another 100 million doses of Pfizer Inc's COVID-19 vaccine, Communications Minister Fabio Faria said on Tuesday, as the country scrambles to procure more shots after a sluggish start to its vaccination program. Brazil is one of the current epicenters of the coronavirus pandemic, driven by a new highly transmissible virus variant, a slow and patchy vaccine rollout and uneven restrictions to help curb the pathogen's spread. Brazil recorded 69,381 new cases of coronavirus and 3,321 new COVID-19 deaths, the Health Ministry said on Tuesday.
Israel is planning a second round of COVID-19 vaccination in six months, by which point it expects children to be approved by health regulators to receive jabs, Prime Minister Benjamin Netanyahu said on Tuesday. Around 81% of Israeli citizens or residents over 16 - the age group eligible for the Pfizer vaccine in Israel - have received both doses in one of the world's fastest rollouts. Israel has said it plans to administer vaccines to 12- to 15-year-olds upon approval by the U.S. Food and Drug Administration (FDA).